Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Graves' disease. Current concepts.

I R McDougall1

  • 1Department of Diagnostic Radiology, Stanford University School of Medicine, California.

The Medical Clinics of North America
|January 1, 1991
PubMed
Summary

Graves' disease is an autoimmune disorder causing thyroid overactivity due to a TSH receptor antibody. Treatment options include medication, surgery, or radioactive iodine (I-131), with I-131 often preferred for its definitive results.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma.

Molecular imaging and biology·2006
Same author

Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?

Molecular imaging and biology·2006
Same author

Long-term results of irradiation for patients with progressive Graves' ophthalmopathy.

International journal of radiation oncology, biology, physics·2001
Same author

Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thyroid Cancer Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001
Same author

Thyroid carcinoma after successful treatment of osteosarcoma: a report of three patients.

Journal of pediatric hematology/oncology·2001
Same author

Positron emission tomography of the thyroid, with an emphasis on thyroid cancer.

Nuclear medicine communications·2001

Area of Science:

  • Endocrinology
  • Immunology
  • Autoimmune Diseases

Background:

  • Graves' disease is an organ-specific autoimmune disorder characterized by thyroid overactivity.
  • The primary mechanism involves antibodies activating the thyroid-stimulating hormone (TSH) receptor on follicular cells.
  • Extrathyroidal manifestations can occur, independent of hyperthyroidism or the specific autoantibody.

Purpose of the Study:

  • To summarize the understanding of Graves' disease, including its pathophysiology, diagnosis, and treatment.
  • To highlight the role of TSH receptor antibodies in thyroid overactivity.
  • To discuss the various therapeutic approaches and their implications.

Main Methods:

  • Review of existing literature on Graves' disease.
  • Clinical diagnostic criteria and laboratory confirmation methods.
  • Evaluation of treatment modalities: antithyroid medication, radioactive iodine (I-131), and thyroidectomy.

Main Results:

  • Clinical diagnosis is typically straightforward, supported by thyroid hormone and TSH measurements.
  • Radioiodine uptake is a valuable diagnostic tool.
  • Treatment aims to normalize thyroid hormone levels, not to correct the underlying immunologic defect.

Conclusions:

  • Radioactive iodine-131 therapy is a safe and definitive treatment option for Graves' disease.
  • Post-treatment hypothyroidism is a common and expected outcome.
  • Lifelong thyroxine replacement is often necessary following I-131 therapy.

Related Experiment Videos